セッション詳細
海外招聘講演3「Ten Years of Transformative Progress in Alzheimer's Dementia Research: From DIAN Insights to AI-Powered Discovery」
2025年11月22日(土) 14:25 〜 15:15
第1会場（朱鷺メッセ 2F メインホール）
座長：池内 健(新潟大学脳研究所 遺伝子機能解析学分野)
[IL3]Ten Years of Transformative Progress in Alzheimer's Dementia Research: From DIAN Insights to AI-Powered Discovery
○Randall J. Bateman
（Charles F. and Joanne Knight Distinguished Professor of Neurology, Washington University School of Medicine; Director, Dominantly Inherited Alzheimer Network (DIAN) and DIAN Trials Unit (DIAN-TU)）
◆略歴
Dr. Randall Bateman is the Charles F. and Joanne Knight Distinguished Professor of Neurology, Co-Director of the Dominantly Inherited Alzheimer Network（DIAN）, Director of the DIAN Trials Unit（DIAN-TU）, Principal Investigator of the Bateman Lab, and Director of the Tracy Family Stable Isotope Labeling Quantitation（SILQ）Center for Neurodegenerative Biology. Dr. Bateman’s research focuses on the pathophysiology and development of improved diagnostics and treatments of Alzheimer’s disease. Dr. Bateman treats patients with dementia at the Memory Diagnostic Center of Washington University.
Dr. Bateman’s lab accomplishments include pioneering the central nervous system Stable Isotope Labeling Kinetics（SILK）measurements in humans, which led to the discovery of the first high-precision blood test for Alzheimer’s disease amyloid plaques in 2017, and subsequent blood tests now utilized by doctors and patients to help diagnose Alzheimer’s disease. Dr. Bateman is a productive innovator with 47 active or pending patents, and co-founder of C2N Diagnostics, which provides high-accuracy blood tests for Alzheimer’s disease. Dr. Bateman has established multiple joint academic and industry research consortia, including the DIAN-TU Pharma Consortium, Tau SILK Consortium, NfL Consortium, and now the Consortium for Biomedical Research Artificial Intelligence in Neurodegeneration（C-BRAIN）.
Dr. Bateman has received a number of awards including the MetLife Foundation Award for Medical Research, the Potamkin Prize, and the CTAD Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research. He is an elected member of the National Academy of Medicine and the National Academy of Inventors.
（Charles F. and Joanne Knight Distinguished Professor of Neurology, Washington University School of Medicine; Director, Dominantly Inherited Alzheimer Network (DIAN) and DIAN Trials Unit (DIAN-TU)）
◆略歴
Dr. Randall Bateman is the Charles F. and Joanne Knight Distinguished Professor of Neurology, Co-Director of the Dominantly Inherited Alzheimer Network（DIAN）, Director of the DIAN Trials Unit（DIAN-TU）, Principal Investigator of the Bateman Lab, and Director of the Tracy Family Stable Isotope Labeling Quantitation（SILQ）Center for Neurodegenerative Biology. Dr. Bateman’s research focuses on the pathophysiology and development of improved diagnostics and treatments of Alzheimer’s disease. Dr. Bateman treats patients with dementia at the Memory Diagnostic Center of Washington University.
Dr. Bateman’s lab accomplishments include pioneering the central nervous system Stable Isotope Labeling Kinetics（SILK）measurements in humans, which led to the discovery of the first high-precision blood test for Alzheimer’s disease amyloid plaques in 2017, and subsequent blood tests now utilized by doctors and patients to help diagnose Alzheimer’s disease. Dr. Bateman is a productive innovator with 47 active or pending patents, and co-founder of C2N Diagnostics, which provides high-accuracy blood tests for Alzheimer’s disease. Dr. Bateman has established multiple joint academic and industry research consortia, including the DIAN-TU Pharma Consortium, Tau SILK Consortium, NfL Consortium, and now the Consortium for Biomedical Research Artificial Intelligence in Neurodegeneration（C-BRAIN）.
Dr. Bateman has received a number of awards including the MetLife Foundation Award for Medical Research, the Potamkin Prize, and the CTAD Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research. He is an elected member of the National Academy of Medicine and the National Academy of Inventors.